Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction
- 3 February 2026
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 108 (3) , 100105
Abstract
No abstract availableKeywords
Funding Information
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Natural Science Foundation of China (81,773,948)
- National Natural Science Foundation of China (J1103507)
- National Natural Science Foundation of China (J1210025)
- Nanjing Drum Tower Hospital
- Nanjing Normal University
This publication has 25 references indexed in Scilit:
- Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkersCancer and Metastasis Reviews, 2023
- ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinomaCancer Letters, 2022
- YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivinCellular Oncology, 2021
- Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signalingBiomedicine & Pharmacotherapy, 2020
- Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growthCancer Letters, 2017
- Cepharanthine alleviates liver injury in a rodent model of limb ischemia–reperfusionActa Anaesthesiologica Taiwanica, 2016
- YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor RegressionCell Reports, 2015
- Hippo Pathway Activity Influences Liver Cell FateCell, 2014
- New antiplasmodial alkaloids from Stephania rotundaJournal of Ethnopharmacology, 2013
- YAP1 Increases Organ Size and Expands Undifferentiated Progenitor CellsCurrent Biology, 2007